---
title: Maravai LifeSciences vs WuXi Biologics
slug_a: maravai
slug_b: wuxibiologics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/maravai/wuxibiologics
---

# Maravai LifeSciences vs WuXi Biologics

Side-by-side profile data from each company listing on this directory.

## Maravai LifeSciences

- Profile: [/companies/maravai](/companies/maravai)

Maravai LifeSciences — Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.

Services: 11. Modalities: 6. Indications: 5. Locations: 0. Certifications: 2. The strongest documented coverage currently appears in services (11).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- mRNA Manufacturing
- Oligonucleotide Manufacturing
- Vaccine Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- mRNA
- Gene Therapy
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Cell-Free

## WuXi Biologics

- Profile: [/companies/wuxibiologics](/companies/wuxibiologics)

WuXi Biologics — Global biologic CDMO offering end-to-end solutions from discovery to commercialization.

Services: 15. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (15).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- ADC (Antibody-Drug Conjugate) Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial